Skip to main content
. Author manuscript; available in PMC: 2024 Dec 1.
Published in final edited form as: J Card Fail. 2023 Jul 13;29(12):1617–1625. doi: 10.1016/j.cardfail.2023.06.021

Table 2.

Survival and Hospitalization Risks by Estimated Glomerular Filtration Rate at Advanced Heart Failure.

Estimated Glomerular Filtration Rate P value
<30 30–44 45–59 ≥60

Mortality
Unadjusted 1.32 (1.10–1.60) 1.25 (1.03–1.51) 1.18 (0.98–1.43) 1.00 (ref) 0.022
Adjusteda 1.30 (1.07–1.57) 1.02 (0.84–1.25) 1.07 (0.88–1.29) 1.00 (ref) 0.039
Cardiovascular Mortality
Unadjusted 1.27 (1.00–1.61) 1.42 (1.13–1.79) 1.21 (0.96–1.54) 1.00 (ref) 0.026
Adjusteda 1.22 (0.96–1.56) 1.09 (0.86–1.38) 1.11 (0.87–1.41) 1.00 (ref) 0.45
All-cause hospitalization
Unadjusted 1.12 (0.89–1.40 0.94 (0.75–1.17) 0.92 (0.76–1.12) 1.00 (ref) 0.28
Adjusteda 1.09 (0.90–1.32) 1.05 (0.88–1.26) 0.96 (0.81–1.26) 1.00 (ref) 0.61
HF hospitalization
Unadjusted 0.86 (0.65–1.14) 0.89 (0.68–1.16) 0.93 (0.71–1.22) 1.00 (ref) 0.75
Adjusteda 0.86 (0.66–1.13) 0.99 (0.77–1.26) 0.97 (0.76–1.23) 1.00 (ref) 0.70
a

Adjusted for age, sex, ejection fraction, body mass index, systolic blood pressure, diabetes, peripheral vascular disease, hypertension, chronic obstructive pulmonary disease, angiotensin converting enzyme inhibitor/ angiotensin receptor blocker/ angiotensin receptor neprilysin inhibitor, beta blocker, mineralocorticoid receptor antagonist.